NCT05118633

Brief Summary

The investigators are testing two digital health interventions for trichotillomania (TTM), via a randomized trial design.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Mar 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Mar 2026Oct 2026

First Submitted

Initial submission to the registry

November 2, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 12, 2021

Completed
4.3 years until next milestone

Study Start

First participant enrolled

March 1, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

February 23, 2026

Status Verified

February 1, 2026

Enrollment Period

6 months

First QC Date

November 2, 2021

Last Update Submit

February 19, 2026

Conditions

Keywords

Hair Pulling DisorderBody-Focused Repetitive BehaviorsTrichotillomaniahabit reversal training

Outcome Measures

Primary Outcomes (1)

  • Clinician-rated trichotillomania (TTM) symptom severity at endpoint (week 8)

    Scores on the NIMH Trichotilomania Severity Scale (NIMH-TSS), a clinician-administered assessment of TTM symptom severity, will be compared across conditions at endpoint (week 8), controlling for baseline severity. The NIMH-TSS is a 5-item clinician rated measure of TTM severity ranging from 0-25, with higher scores indicating more severe symptoms.

    Eight weeks

Secondary Outcomes (1)

  • Self-reported trichotillomania (TTM) severity at endpoint (week 8)

    8 weeks

Study Arms (2)

Keen2 bracelet and app

EXPERIMENTAL

8-week intervention involving a wrist-worn motion detection device (Keen2 bracelet) and accompanying smartphone app that delivers components of behavior therapy for TTM.

Device: Keen2 braceletBehavioral: Keen2 app

Reminder bracelet and health tips app

PLACEBO COMPARATOR

8-week intervention involving a wrist-worn reminder device (non-vibrating bracelet) and accompanying smartphone app that prompts for general context logging and delivers general health tips.

Device: Reminder braceletBehavioral: Health Reminders App

Interventions

Participants will receive an awareness bracelet (Keen2) which vibrates upon detection of hair pulling motion, supporting behavior therapy for hair pulling delivered by the Keen2 app.

Keen2 bracelet and app

Participants will receive a non-vibrating bracelet to wear as a visual reminder not to pull.

Reminder bracelet and health tips app
Keen2 appBEHAVIORAL

Participants will be given access to a smartphone app. The bracelet and app work together to implement key features of habit reversal training for TTM, including psychoeducation, awareness training, competing response training, and personalized just-in-time stimulus control and other behavioral strategy reminders.

Keen2 bracelet and app

Participants will be given access to a smartphone app that will prompt them to log their context (e.g., location and activity) throughout the day and provide general health tips.

Reminder bracelet and health tips app

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older (criterion 1a) with a diagnosis of TTM focused on primary hair pulling location(s) above the neck (e.g., scalp, eyebrows, eye lashes, beard) (criterion 1b).
  • English language fluency (criterion 2).
  • Report no current pharmacological intervention targeting TTM symptoms OR a 6-week course of the intervention without change in dosage and intent for that dosage to remain stable for the 12 weeks of this trial (criterion 3a).
  • Report no current psychosocial intervention targeting TTM (criterion 3b)
  • \. Reliable and consistent access to the internet and/or mobile device permitting the participant to meet with someone virtually for 90 min.
  • \. Owns a mobile phone running on Apple's operating system (iOS 6+) 6. Identifies a support person that is able to be contacted if an emergency arises.

You may not qualify if:

  • Current suicidal/homicidal ideation, intent, or plan (criterion 1a) or a diagnosis of another psychiatric condition that may impede a participant's ability to fully utilize the app (e.g., psychotic disorder, eating disorder, moderate to severe major depressive disorder \[defined by meeting diagnostic criteria on the MINI and a score \>13 on DASS-21\]) (criterion 1b)
  • Has not used HabitAware's Keen or Keen2 bracelet in the past 24 months.
  • Residing outside the United States

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Trichotillomania

Condition Hierarchy (Ancestors)

Obsessive-Compulsive DisorderAnxiety DisordersMental DisordersDisruptive, Impulse Control, and Conduct Disorders

Central Study Contacts

Sameer Kumar, BS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 2, 2021

First Posted

November 12, 2021

Study Start

March 1, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

February 23, 2026

Record last verified: 2026-02